1. The significant association between health examination results and population health: A cross-sectional ecological study using a nation-wide health check-up database in Japan. Yukinori Nagakura, Hideaki Kato, Satoshi Asano, Yasuhiro Jinno, Shigeharu TaneiInternational Journal of Environmental Research and Public Health 18 836-849 2021
2. Effects of the;K;channel opener KR;on the cardiovascular metabolic syndrome model in rats Okada Y, Yoshino T, Takeuchi A, Endoh M, Ohta H, Jinno Y, Yokoyama T, Izawa TJ Cardiovasc Pharmacol 35 287-293 2000
3. Protective Effect of the K+ Channel Opener KRN4884 on Peripheral Occlusive Arterial Disease in Rats. T Yoshino, H Ohta, Y Jinno, Y Torii, N Ogawa, T Izawa Y, OkadaGen Pharmacol 31 59-62 1998
4. KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs. Kawahara J, Jinno Y, Endo M, Izumi H, Takeuchi A, Izawa TJ Cardiovasc Pharmacol 29 814-819 1997
5. Effect of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with Levcromakalim, Nilvadipine and Nifedipine. H Izumi, Y Jinno, S Kaneta, Y Tanaka, Y Okada, T Izawa, N OgawaJ Cardiovasc Pharmacol 26 189-197 1995
6. Effect of KRN2391 on canine ventricular arrhythmia models. Takeuchi A, Harada K, Miwa A, Jinno Y, Kaneta S, Yokoyama T, Ogawa NGen Pharmacol 25 53-60 1994
7. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart. Miwa A, Jinno Y, Yokoyama T, Izawa T, Ogawa NGen Pharmacol 25 471-474 1994
8. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig. Harada K, Miwa A, Yokoyama T, Izawa T, Ogawa N, Jinno YGen Pharmacol 25 935-939 1994
9. Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, Yokoyama T, Okada Y, Jinno Y, Izumi H, Izawa T, Ogawa NGen Pharmacol 25 941-945 1994
10. Comparison of the effects of KRN2391 and other coronary dilators on porcine isolated coronary arteries of different sizes. Kasai H, Jinno Y, Kaneta S, Fukata Y, Fukushima H, Ogawa NJ Pharm Pharmacol 45 573-575 1993
11. Effect of KRN2391 on venous return: comparison with other vasodilators. Kaneta S, Jinno Y, Miwa A, Fukushima H, Ogawa NJ Cardiovasc Pharmacol 22 82-88 1993
12. Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery. Okada Y, Yokoyama T, Jinno Y, Kashiwabara T, Izawa T, Fukushima H, Ogawa NEur J Pharmacol 241 177-181 1993
13. Effect of KRN2391, a novel vasodilator, on endothelin-1-induced contraction of porcine coronary artery: comparison with cromakalim, nitroglycerin and nifedipine. Miwa A, Kasai H, Motoki K, Jinno Y, Yokoyama T, Fukushima H, Ogawa NArch Int Pharmacodyn Ther 326 52-61 1993
14. Hemodynamic Profile of KRN2391, a novel vasodilator, in anesthetized dogs. Ogawa N, Jinno Y, Kaneta S, Harada K, Fukata Y, Fukushima HJ Cardiovasc Pharmacol 21 874-882 1993
15. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes. A Miwa, S Kaneta, K Motoki, Y Jinno, H Kasai, Y Okada, H Fukushima, N OgawaBr J Pharmacol 109 632-636 1993
16. Mechanism of Action of KRN2391, a Novel Vasodilator, in Canine Mesenteric Artery. N Ogawa, Y Fukata, S Kaneta, Y Jinno, A Miwa H FukushimaJapan J Pharmacol 61 303-30 1993
17. Mechanism of Action of KRN2391 in Canine Coronary Vascular Bed. N Ogawa, Y Fukata, S Kaneta, Y Jinno, A Miwa H FukushimaJapan J Pharmacol 63 305-311 1993
18. Effects of K + channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart. H. Ohta, H. Nakazawa, Y. Jinno, K. Harada, N. Ogawa, A. Miwa, K. NishikoriEur J Phamacol 231 323-330 1993
19. Comparison of the anti-vasoconstrictor effects of a novel vasodilator KRN2391, nicorandil and nifedipine on isolated porcine large coronary artery. H. Kasai, Y. Jinno, S, Kaneta, T. Tanaka, H. Fukushima, T. Izawa, N. OgawaArch Int Pharmacodyn Ther 321: 63-71 1993
20. Inotropic and chronotropic effects of KRN2391, a novel vasodilator, on isolated guinea-pig. Y. Jinno, S. Kaneta, H. Ohta, H. Fukushima, T. Izawa, N. OgawaAsia Pacific J Pharmacol 8 23-27 1993
21. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. J Cardiovasc Pharmacol. Ogawa N, Fukata Y, Kaneta S, Jinno Y, Fukushima H, Nishikori KJ Cardiovasc Pharmacol 20 11-17 1992
22. Tolerance to the increase in coronary blood flow induced by KRN2391. Kaneta S, Jinno Y, Harada K, Fukushima H, Ogawa NArch Int Pharmacodyn Ther 318 21-35 1992
23. Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs. Ogawa N, Kaneta S, Jinno Y, Kasai H, Nishikori K, Fukushima HArch Int Pharmacodyn Ther 318 36-46 1992
24. Contribution of cyclic GMP formation to KRN2391-induced relaxation in porcine coronary artery of the pig. Y. Jinno, H. Kasai, H. Ohta, K. Nishikori, H. Fukushima, N. OgawaBr. J . Pharmacol 106 906-909 1992
25. Contribution of cyclic GMP formation to KRN2391-induced relaxation in porcine coronary artery of the pig. Y. Jinno, H. Kasai, H. Ohta, K. Nishikori, H. Fukushima, N. OgawaBr. J . Pharmacol 106 906-909 1992
26. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. H. Ohta, Y. Jinno, K. Harada, N. Ogawa, H. Fukushima, K. NishikoriEur J PharmacoI 204 171-177 1991